Kalaris Therapeutics (KLRS) Free Cash Flow by Year
Kalaris Therapeutics, Inc. recorded an outflow of $38.6M in free cash flow in fiscal year 2025. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Kalaris Therapeutics, Inc. has filed alongside them.
Ticker history: ALVR became KLRS (Kalaris Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View ALVR history.
Annual figures, oldest first. Point at a bar to read its period.
KLRS Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
KLRS Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Kalaris Therapeutics, Inc. financials
Frequently Asked Questions
Kalaris Therapeutics, Inc. recorded an outflow of $38.6M in free cash flow in fiscal year 2025.
Across the 7 fiscal years this page covers, Kalaris Therapeutics, Inc. (KLRS) free cash flow went from -$20.5M in fiscal year 2019 to -$38.6M in fiscal year 2025.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Kalaris Therapeutics, Inc. (KLRS) reported on that line in every period on record.